{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:31:36Z","timestamp":1793856696107,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Simons Support"},{"name":"the National Research Foundation of Ukraine","id":[{"id":"https:\/\/ror.org\/02gmp5156","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10529-026-03793-7","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:09:11Z","timestamp":1791083351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibitors of Mycobacterium tuberculosis methionyl-tRNA synthetase are sensitive to the mutations E24A and L293A in aminoacyl-adenylate binding site"],"prefix":"10.1007","volume":"48","author":[{"given":"Galyna P.","family":"Volynets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia O.","family":"Usenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana B.","family":"Gorbatiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry M.","family":"Irodov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy S.","family":"Lukashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodymyr G.","family":"Bdzhola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana V.","family":"Antonenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana V.","family":"Marchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy S.","family":"Tarnavskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy M.","family":"Yarmoluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandra I.","family":"Skydanovych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Tukalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,4]]},"reference":[{"key":"3793_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1039\/c2md20032e","volume":"3","author":"V Agarwal","year":"2012","unstructured":"Agarwal V, Nair SK (2012) Aminoacyl tRNA synthetases as targets for antibiotic development. Med Chem Commun 3:887\u2013898. https:\/\/doi.org\/10.1039\/c2md20032e","journal-title":"Med Chem Commun"},{"key":"3793_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1107\/S2053230X18003151","volume":"74","author":"X Barros-\u00c1lvarez","year":"2018","unstructured":"Barros-\u00c1lvarez X, Turley S, Ranade RM, Gillespie JR, Duster NA, Verlinde CLMJ, Fan E, Buckner FS, Hol WGJ (2018) The crystal structure of the drug target Mycobacterium tuberculosis methionyl-tRNA synthetase in complex with a catalytic intermediate. Acta Crystallogr F Struct Biol Commun 74:245\u2013254. https:\/\/doi.org\/10.1107\/S2053230X18003151","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"3793_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmi.2025.09.003","volume":"32","author":"D Chesov","year":"2026","unstructured":"Chesov D, Reimann M, Mukherjee T et al (2026) High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova. Clin Microbiol Infect 32:177\u2013180. https:\/\/doi.org\/10.1016\/j.cmi.2025.09.003","journal-title":"Clin Microbiol Infect"},{"key":"3793_CR4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3109\/14756366.2016.1140754","volume":"31","author":"AG Eissa","year":"2016","unstructured":"Eissa AG, Blaxland JA, Williams RO et al (2016) Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives. J Enzyme Inhib Med Chem 31:1694\u20131697. https:\/\/doi.org\/10.3109\/14756366.2016.1140754","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3793_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00999-17","volume":"61","author":"O Faghih","year":"2017","unstructured":"Faghih O, Zhang Z, Ranade RM et al (2017) Development of methionyl-tRNA synthetase inhibitors as antibiotics for gram-positive bacterial infections. Antimicrob Agents Chemother 61:e00999-17. https:\/\/doi.org\/10.1128\/AAC.00999-17","journal-title":"Antimicrob Agents Chemother"},{"key":"3793_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","volume":"22","author":"M Farhat","year":"2024","unstructured":"Farhat M, Cox H, Ghanem M et al (2024) Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol 22:617\u2013635. https:\/\/doi.org\/10.1038\/s41579-024-01025-1","journal-title":"Nat Rev Microbiol"},{"key":"3793_CR7","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1074\/jbc.REV118.002956","volume":"294","author":"CS Francklyn","year":"2019","unstructured":"Francklyn CS, Mullen P (2019) Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics. J Biol Chem 294:5365\u20135385. https:\/\/doi.org\/10.1074\/jbc.REV118.002956","journal-title":"J Biol Chem"},{"key":"3793_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00194-25","volume":"39","author":"R Gopalaswamy","year":"2026","unstructured":"Gopalaswamy R, Subbian S (2026) The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management. Clin Microbiol Rev 39:e00194-25. https:\/\/doi.org\/10.1128\/cmr.00194-25","journal-title":"Clin Microbiol Rev"},{"key":"3793_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/AAC.00275-08","volume":"53","author":"LS Green","year":"2009","unstructured":"Green LS, Bullard JM, Ribble W, Dean F, Ayers DF, Ochsner UA, Janjic N, Jarvis TC (2009) Inhibition of methionyl-tRNA synthetase by REP8839 and effects of resistance mutations on enzyme activity. Antimicrob Agents Chemother 53:86\u201394. https:\/\/doi.org\/10.1128\/AAC.00275-08","journal-title":"Antimicrob Agents Chemother"},{"key":"3793_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.807095","volume":"12","author":"Q Guo","year":"2022","unstructured":"Guo Q, Bi J, Lin Q, Ye T, Wang Z, Wang Z, Liu L, Zhang G (2022) Whole genome sequencing identifies novel mutations associated with bedaquiline resistance in Mycobacterium tuberculosis. Front Cell Infect Microbiol 12:807095. https:\/\/doi.org\/10.3389\/fcimb.2022.807095","journal-title":"Front Cell Infect Microbiol"},{"key":"3793_CR11","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.bmcl.2017.04.048","volume":"27","author":"W Huang","year":"2017","unstructured":"Huang W, Zhang Z, Ranade RM et al (2017) Optimization of a binding fragment targeting the \u201cenlarged methionine pocket\u201d leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitors. Bioorg Med Chem Lett 27:2702\u20132707. https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.048","journal-title":"Bioorg Med Chem Lett"},{"key":"3793_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev.biochem.69.1.617","volume":"69","author":"M Ibba","year":"2000","unstructured":"Ibba M, S\u00f6ll D (2000) Aminoacyl-tRNA synthesis. Annu Rev Biochem 69:617\u2013650. https:\/\/doi.org\/10.1146\/annurev.biochem.69.1.617","journal-title":"Annu Rev Biochem"},{"key":"3793_CR13","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/jcc.27390","volume":"45","author":"M Kabier","year":"2024","unstructured":"Kabier M, Gambacorta N, Trisciuzzi D, Kumar S, Nicolotti O, Mathew B (2024) MzDOCK: a free ready-to-use GUI-based pipeline for molecular docking simulations. J Comput Chem 45:1980\u20131986. https:\/\/doi.org\/10.1002\/jcc.27390","journal-title":"J Comput Chem"},{"key":"3793_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12936-016-1247-0","volume":"15","author":"S Khan","year":"2016","unstructured":"Khan S (2016) Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases. Malar J 15:203. https:\/\/doi.org\/10.1186\/s12936-016-1247-0","journal-title":"Malar J"},{"key":"3793_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jinf.2023.01.039","volume":"86","author":"N Koehler","year":"2023","unstructured":"Koehler N, Andres S, Merker M et al (2023) Pretomanid-resistant tuberculosis. J Infect 86:520\u2013524. https:\/\/doi.org\/10.1016\/j.jinf.2023.01.039","journal-title":"J Infect"},{"key":"3793_CR16","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1039\/c9md00347a","volume":"10","author":"OP Kovalenko","year":"2019","unstructured":"Kovalenko OP, Volynets GP, Rybak MY et al (2019) Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N\u2019-thiazol-2-yl-hydrazines. Medchemcomm 10:2161\u20132169. https:\/\/doi.org\/10.1039\/c9md00347a","journal-title":"Medchemcomm"},{"key":"3793_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","volume":"18","author":"NH Kwon","year":"2019","unstructured":"Kwon NH, Fox PL, Kim S (2019) Aminoacyl-tRNA synthetases as therapeutic targets. Nat Rev Drug Discov 18:629\u2013650. https:\/\/doi.org\/10.1038\/s41573-019-0026-3","journal-title":"Nat Rev Drug Discov"},{"key":"3793_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00531-22","volume":"66","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shi J, Li L, Wu T, Chu P, Pang Y, Guo Y, Gao M, Lu J (2022) Spontaneous mutational patterns and novel mutations for delamanid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 66:e0053122. https:\/\/doi.org\/10.1128\/aac.00531-22","journal-title":"Antimicrob Agents Chemother"},{"key":"3793_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/open.202400460","volume":"14","author":"R Maharjan","year":"2025","unstructured":"Maharjan R, Gyawali K, Acharya A, Khanal M, Khanal K, Kshetri MB, Ghimire MP, Lamichhane TR (2025) Machine learning-based high-throughput screening, molecular modeling and quantum chemical analysis to investigate Mycobacterium tuberculosis MetRS ihibitors. ChemistryOpen 14:e202400460. https:\/\/doi.org\/10.1002\/open.202400460","journal-title":"ChemistryOpen"},{"key":"3793_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7124\/bc.000B3C","volume":"42","author":"MV Mahdysiuk","year":"2026","unstructured":"Mahdysiuk MV, Volynets GP, Tarnavskiy SS et al (2026) 2,4-Dianilino-pyrimidine derivatives as submicromolar CK2 inhibitors. Biopolym Cell 42:121\u2013128. https:\/\/doi.org\/10.7124\/bc.000B3C","journal-title":"Biopolym Cell"},{"key":"3793_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160350","volume":"11","author":"KK Ojo","year":"2016","unstructured":"Ojo KK, Ranade RM, Zhang Z et al (2016) Brucella melitensis methionyl-tRNA-synthetase (MetRS), a potential drug target for brucellosis. PLoS ONE 11:e0160350. https:\/\/doi.org\/10.1371\/journal.pone.0160350","journal-title":"PLoS ONE"},{"key":"3793_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07861-x","volume":"22","author":"H Pai","year":"2022","unstructured":"Pai H, Ndjeka N, Mbuagbaw L et al (2022) Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis. BMC Infect Dis 22:870. https:\/\/doi.org\/10.1186\/s12879-022-07861-x","journal-title":"BMC Infect Dis"},{"key":"3793_CR23","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/ijms22041750","volume":"22","author":"L Pang","year":"2021","unstructured":"Pang L, Weeks SD, Van Aerschot A (2021) Aminoacyl-tRNA synthetases as valuable targets for antimicrobial drug discovery. Int J Mol Sci 22:1750. https:\/\/doi.org\/10.3390\/ijms22041750","journal-title":"Int J Mol Sci"},{"key":"3793_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071927","volume":"11","author":"S Park","year":"2022","unstructured":"Park S, Jung J, Kim J, Han SB, Ryoo S (2022) Investigation of clofazimine resistance and genetic mutations in drug-resistant Mycobacterium tuberculosis isolates. J Clin Med 11:1927. https:\/\/doi.org\/10.3390\/jcm11071927","journal-title":"J Clin Med"},{"key":"3793_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.152858","volume":"370","author":"A Rajput","year":"2026","unstructured":"Rajput A, Thakur S, Mehra R (2026) Molecular recognition of substrate intermediate and inhibitors by tryptophanyl-tRNA synthetase from Mycobacterium tuberculosis. Int J Biol Macromol 370:152858. https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152858","journal-title":"Int J Biol Macromol"},{"key":"3793_CR26","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1128\/AAC.00674-16","volume":"60","author":"C Randall","year":"2016","unstructured":"Randall C, Rasina D, Jirgensons A, O\u2019Neill A (2016) Targeting multiple aminoacyl-tRNA synthetases overcomes the resistance liabilities associated with antibacterial inhibitors acting on a single such enzyme. Antimicrob Agents Chemother 60:6359\u20136361. https:\/\/doi.org\/10.1128\/AAC.00674-16","journal-title":"Antimicrob Agents Chemother"},{"key":"3793_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1570163814666170330100238","volume":"14","author":"S Robles","year":"2017","unstructured":"Robles S, Hu Y, Resto T, Dean F, Bullard JM (2017) Identification and characterization of a chemical compound that inhibits methionyl-tRNA synthetase from Pseudomonas aeruginosa. Curr Drug Discov Technol 14:156\u2013168. https:\/\/doi.org\/10.2174\/1570163814666170330100238","journal-title":"Curr Drug Discov Technol"},{"key":"3793_CR28","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2022-0261","volume":"46","author":"NO Rossini","year":"2023","unstructured":"Rossini NO, Dias MVB (2023) Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line. Genet Mol Biol 46:e20220261. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2022-0261","journal-title":"Genet Mol Biol"},{"key":"3793_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86562-y","volume":"11","author":"MYu Rybak","year":"2021","unstructured":"Rybak MYu, Balanda AO, Yatsyshyna AP et al (2021) Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases. Sci Rep 11:7162. https:\/\/doi.org\/10.1038\/s41598-021-86562-y","journal-title":"Sci Rep"},{"key":"3793_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2026.109382","volume":"46","author":"S Saxena","year":"2026","unstructured":"Saxena S, Guruprasad L (2026) Elucidating the structural basis of Fgd1-mediated resistance to delamanid in Mycobacterium tuberculosis. J Mol Graph Model 46:109382. https:\/\/doi.org\/10.1016\/j.jmgm.2026.109382","journal-title":"J Mol Graph Model"},{"key":"3793_CR31","doi-asserted-by":"publisher","first-page":"2501531","DOI":"10.1183\/13993003.01531-2025","volume":"67","author":"JA Schildkraut","year":"2026","unstructured":"Schildkraut JA, Flood D, Sloan DJ, Heinrich N, Fox S, Lange C, Wells C, Tiberi S (2026) Rising bedaquiline resistance: exploring potential causes and next steps. Eur Respir J 67:2501531. https:\/\/doi.org\/10.1183\/13993003.01531-2025","journal-title":"Eur Respir J"},{"key":"3793_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00284-025-04655-7","volume":"83","author":"I Singh","year":"2025","unstructured":"Singh I, Sharma J, Sharma D, Ratn A, Bisht D, Sharma S, Dhakad MS, Dalal J, Beg MMA (2025) Bedaquiline resistance: a looming global threat in tuberculosis management. Curr Microbiol 83:57. https:\/\/doi.org\/10.1007\/s00284-025-04655-7","journal-title":"Curr Microbiol"},{"key":"3793_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag488","volume":"54","author":"J Su","year":"2026","unstructured":"Su J, Qiao A, Huang W, Xu J, Lu F, Zhang H, Deng Q, Zou J, Wang Z, Lei J, Zhou H (2026) Discovery of a triple-site inhibitor targeting bacterial methionyl-tRNA synthetase through combined drug repurposing screening and generative AI-assisted optimization. Nucleic Acids Res 54:gkag488. https:\/\/doi.org\/10.1093\/nar\/gkag488","journal-title":"Nucleic Acids Res"},{"key":"3793_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10930-023-10135-3","volume":"42","author":"S Thakur","year":"2023","unstructured":"Thakur S, Mehra R (2023) Computational insight into substrate-induced conformational changes in methionyl-tRNA synthetase of Mycobacterium tuberculosis. Protein J 42:533\u2013546. https:\/\/doi.org\/10.1007\/s10930-023-10135-3","journal-title":"Protein J"},{"key":"3793_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2025.06.06.658285","volume":"0","author":"S Thakur","year":"2025","unstructured":"Thakur S, Mehra R (2025) Distinct substrate and intermediate recognition via mutation effects on Mycobacterium tuberculosis methionyl-tRNA synthetase. Proteins Struct Funct Bioinf 0:1\u201329. https:\/\/doi.org\/10.1101\/2025.06.06.658285","journal-title":"Proteins Struct Funct Bioinf"},{"key":"3793_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110939","volume":"302","author":"S Thakur","year":"2026","unstructured":"Thakur S, Mehra R (2026) Initiator and elongator tRNA recognition mechanism in Mycobacterium tuberculosis methionyl-tRNA synthetase. J Biol Chem 302:110939. https:\/\/doi.org\/10.1016\/j.jbc.2025.110939","journal-title":"J Biol Chem"},{"key":"3793_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12941-024-00741-z","volume":"23","author":"L Vasiliauskait\u0117","year":"2024","unstructured":"Vasiliauskait\u0117 L, Baku\u0142a Z, Vasiliauskien\u0117 E et al (2024) Detection of multidrug-resistance in Mycobacterium tuberculosis by phenotype- and molecular-based assays. Ann Clin Microbiol Antimicrob 23:81. https:\/\/doi.org\/10.1186\/s12941-024-00741-z","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"3793_CR38","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10822-019-00245-5","volume":"33","author":"GP Volynets","year":"2019","unstructured":"Volynets GP, Starosyla SA, Rybak MY et al (2019) Dual-targeted hit identification using pharmacophore screening. J Comput Aided Mol des 33:955\u2013964. https:\/\/doi.org\/10.1007\/s10822-019-00245-5","journal-title":"J Comput Aided Mol des"},{"key":"3793_CR39","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.4155\/fmc-2022-0085","volume":"14","author":"GP Volynets","year":"2022","unstructured":"Volynets GP, Usenko MO, Gudzera OI et al (2022) Identification of dual-targeted Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning. Future Med Chem 14:1223\u20131237. https:\/\/doi.org\/10.4155\/fmc-2022-0085","journal-title":"Future Med Chem"},{"key":"3793_CR40","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1080\/07391102.2022.2107574","volume":"41","author":"GP Volynets","year":"2023","unstructured":"Volynets GP, Gudzera OI, Usenko MO, Gorbatiuk OB, Yarmoluk SM, Tukalo MA (2023) Probing interactions of aminoacyl-adenylate with Mycobacterium tuberculosis methionyl-tRNA synthetase through in silico site-directed mutagenesis and free energy calculation. J Biomol Struct Dyn 41:6450\u20136458. https:\/\/doi.org\/10.1080\/07391102.2022.2107574","journal-title":"J Biomol Struct Dyn"},{"key":"3793_CR41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1107\/S2052252518008217","volume":"5","author":"W Wang","year":"2018","unstructured":"Wang W, Qin B, Wojdyla JA, Wang M, Gao X, Cui S (2018) Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism. IUCrJ 5:478\u2013490. https:\/\/doi.org\/10.1107\/S2052252518008217","journal-title":"IUCrJ"},{"key":"3793_CR42","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1039\/c9md00139e","volume":"10","author":"P Zhang","year":"2019","unstructured":"Zhang P, Ma S (2019) Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents. Medchemcomm 10:1329\u20131341. https:\/\/doi.org\/10.1039\/c9md00139e","journal-title":"Medchemcomm"},{"key":"3793_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00485-23","volume":"61","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lam C, Martinez E, Sim E, Crighton T, Marais BJ, Sintchenko V (2023) Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants. J Clin Microbiol 61:e0048523. https:\/\/doi.org\/10.1128\/jcm.00485-23","journal-title":"J Clin Microbiol"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-026-03793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-026-03793-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-026-03793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:23:41Z","timestamp":1793856221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-026-03793-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3793"],"URL":"https:\/\/doi.org\/10.1007\/s10529-026-03793-7","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"126"}}